Global Cancer Diagnostics Market is expected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Free Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market-1

Technological Advancements And Innovations In Cancer Diagnostics Market
The Cancer Diagnostics Technology Market is expected to show significant growth in the coming years due to various technological advancements and new product launches in order to improve the convenience and ease of administration of parenteral therapeutics.

Segmentation:
· By Technology
o Platform Based (Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next Generation Sequencing (NGS), DNA microarrays, flow cytometry and others);
o Instrument Based {Imaging (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron
Emission Tomography- Computed Tomography (PET-CT), mammography and ultrasound), Biopsy}
· By Applications (lung cancer, breast cancer, colorectal cancer, melanoma, and others),
· By Geography (North America, Europe, Asia-Pacific, South America, Middle East Africa)

Drivers:
· Some of the major factors driving the market for cancer diagnostics market are growing aging population worldwide, government initiatives for funding, and awareness about cancer.
· These factors increase the demand for cancer diagnostics products.
· Increasing prevalence of cancer, key players focusing on strategic decisions and technological advancements are the major factors driving the growth of the cancer diagnostics market.

Major Players:
Some of the major players operating in this market are:
· Agilent Technologies,
· Abbott,
· Thermo Fisher Scientific,
· Becton, Dickinson and Company,
· GE Healthcare,
· QIAGEN,
· Illumina Inc.,
· F. Hoffmann-La Roche Ltd.,
· Siemens Healthcare GmbH, and
· Koninklijke Philips N.V., among others.

Please Check Exclusive Industry News @ https://databridgemarketresearch.com/news/product-launch/global-cancer-diagnostics-market-1/

About Us:
Data Bridge Market Research adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us-
Data Bridge Market Research
US: +1–888–387–2818
Email: [email protected]
Website: https://databridgemarketresearch.com